Hot Undervalued Stocks To Invest In Right Now


In November 2017, chip giant Broadcom (NASDAQ:AVGO) offered to buy fellow chipmakerQualcomm (NASDAQ:QCOM) for $70 per share, a 28% premium to Qualcomm’s closing price before speculation about the bid leaked. Qualcomm shares had been significantly depressed prior to Broadcom’s offer amid an ugly legal battle with Apple (NASDAQ:AAPL) that threatened to destroy Qualcomm’s wireless technology licensing operation — its biggest profit center.

Qualcomm wasn’t happy with the offer, but Broadcom wasn’t willing to give up so easily. In February, Broadcom bumped its offer up to $82 per share — an offer that Qualcomm still wasn’t happy with.


Though Qualcomm’s board of directors rejected the $82-per-share offer, claiming that it undervalued the company, Broadcom seemed to have significant shareholder support for its offer. Indeed, Qualcomm shareholders were on track to vote out the current board of directors and vote in a slate of directors hand-picked by Broadcom to approve this deal when President Trump issued an executive order blocking the takeover bid.

Hot Undervalued Stocks To Invest In Right Now: Cerner Corporation(CERN)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Shineco, Inc. (NASDAQ: TYHT) rose 34.7 percent to $2.29 in pre-market trading following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million.
    Carver Bancorp, Inc. (NASDAQ: CARV) rose 15.8 percent to $12.74 in pre-market trading after surging 201.37 percent on Thursday.
    LiveXLive Media, Inc. (NASDAQ: LIVX) shares rose 11.5 percent to $7.75 in pre-market trading after climbing 64.50 percent on Thursday.
    Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) rose 9 percent to $18.30 in pre-market trading after climbing 41.77 percent on Thursday.
    AmTrust Financial Services Inc (NASDAQ: AFSI) rose 6.2 percent to $14.25 in pre-market trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction.
    Cerner Corporation (NASDAQ: CERN) rose 5.6 percent to $64.02 in pre-market trading after the Department of Veterans Affairs reported an agreement with Cerner Government Services, Inc. to provide seamless care for veterans.
    PetroChina Company Limited (NYSE: PTR) shares rose 5.3 percent to $82.05 in pre-market trading.
    TC PipeLines, LP (NYSE: TCP) shares rose 5.2 percent to $26.59 in the pre-market trading session.
    IQVIA Holdings Inc. (NYSE: IQV) shares rose 4.8 percent to $102.50 in pre-market trading as the company pulled secondary offering 'in light of recent market conditions'.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 4.5 percent to $59.70 in pre-market trading. On Thursday, Axon priced its 4.3 million share offering of common stock at $53 per share.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 4.5 percent to $84 in pre-market trading.
    PetIQ Inc (NASDAQ: PETQ) rose 3.9 percent to $18.96 in pre-market trading after a 13G filing shows a new 5.05 percent stake by the State of New Jersey's Division of Investment.
    Mattel, Inc. (NASDAQ: MAT) shares rose 3.7 percent to $15.85 in pre-market
  • [By Ethan Ryder]

    Cerner (NASDAQ:CERN) had its price objective decreased by SunTrust Banks to $58.00 in a research report sent to investors on Friday, The Fly reports. SunTrust Banks also issued estimates for Cerner’s Q1 2018 earnings at $0.55 EPS, Q2 2018 earnings at $0.60 EPS, Q3 2018 earnings at $0.65 EPS and Q4 2018 earnings at $0.64 EPS.

  • [By Joseph Griffin]

    Quadrature Capital Ltd acquired a new stake in Cerner Co. (NASDAQ:CERN) in the first quarter, according to its most recent filing with the SEC. The fund acquired 4,557 shares of the company’s stock, valued at approximately $264,000.

  • [By Shane Hupp]

    Rockefeller Capital Management L.P. acquired a new position in shares of Cerner (NASDAQ:CERN) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,402,230 shares of the company’s stock, valued at approximately $81,329,000. Cerner comprises 1.3% of Rockefeller Capital Management L.P.’s portfolio, making the stock its 22nd largest holding.

  • [By Logan Wallace]

    Wilkins Investment Counsel Inc. boosted its holdings in Cerner (NASDAQ:CERN) by 14.9% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,650 shares of the company’s stock after purchasing an additional 2,425 shares during the quarter. Wilkins Investment Counsel Inc.’s holdings in Cerner were worth $1,082,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Cerner (CERN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Undervalued Stocks To Invest In Right Now: Imprimis Pharmaceuticals, Inc.(IMMY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Headlines about Imprimis Pharmaceuticals (NASDAQ:IMMY) have been trending positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imprimis Pharmaceuticals earned a daily sentiment score of 0.25 on Accern’s scale. Accern also gave media headlines about the specialty pharmaceutical company an impact score of 47.393314841388 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st
  • [By Lisa Levin] Gainers
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results.
    Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018.
    HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat.
    Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday.
    Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile.
    Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results.
    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter.
    PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t

Hot Undervalued Stocks To Invest In Right Now: Crown Holdings, Inc.(CCK)


Advisors’ Opinion:

  • [By Shane Hupp]

    Crown Holdings (NYSE:CCK) has been assigned an average recommendation of “Hold” from the sixteen brokerages that are currently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have issued a buy rating on the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $63.64.

Hot Undervalued Stocks To Invest In Right Now: Celldex Therapeutics Inc(CLDX)


Advisors’ Opinion:

  • [By Motley Fool Staff]

    Celldex (NASDAQ:CLDX) has unveiled thoroughly disappointing results for its lead drug, glembatumumab vedotin (glemba), that casts doubt on its future. Can the company bounce back from this failure?

  • [By Paul Ausick]

    Celldex Therapeutics Inc. (NASDAQ: CLDX) dropped about 1.6% Wednesday to post a new 52-week low of $0.62. Shares closed at $0.63 on Tuesday and the stock’s 52-week high is $3.26. Volume of around 3.1 million shares was roughly equal to the daily average.The company had no specific news.

  • [By Paul Ausick]

    Celldex Therapeutics Inc. (NASDAQ: CLDX) fell by about 7.6% Wednesday to post a new 52-week low of $0.72 after closing at $0.79 on Tuesday. The 52-week high is $3.42. Volume of about 9 million was more than four times the daily average of about 2 million. The company continues to get beaten up following a failed breast cancer drug study.

  • [By Motley Fool Staff]

    In this segment, he shares an email — and a scorecard — from a listener who took a bit of a leap of faith. At the beginning of 2017, he opened positions in the five biggest losers in the Rule Breaker universe for 2016: Restoration Hardware (NYSE:RH), Juno Therapeutics,FireEye (NASDAQ:FEYE),GoPro (NASDAQ:GPRO), and Celldex Therapeutics (NASDAQ:CLDX). True, the Fool doesn’t usually suggest adding to your losers, but as Arlo points out, they were still active recommendations, and he didn’t own any shares of them. So how’d those stocks do from there? Well, without spoiling it, let’s say he didn’t bat 1000 — but Foolish investors don’t have to.

  • [By George Budwell]

    Shares of Celldex Therapeutics (NASDAQ:CLDX), a small-cap cancer company, are down by over 43% in pre-market trading today on extremely heavy volume. What’s going on?

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Celldex Therapeutics (CLDX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Undervalued Stocks To Invest In Right Now: Saul Centers, Inc.(BFS)


Advisors’ Opinion:

  • [By Stephan Byrd]

    Teachers Insurance & Annuity Association of America purchased a new position in shares of Saul Centers, Inc. (NYSE:BFS) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 13,437 shares of the real estate investment trust’s stock, valued at approximately $685,000. Teachers Insurance & Annuity Association of America owned approximately 0.06% of Saul Centers at the end of the most recent quarter.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Saul Centers (BFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Saul Centers (BFS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Shares of Saul Centers, Inc. (NYSE:BFS) have been assigned a consensus recommendation of “Hold” from the seven analysts that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $54.50.

Leave a Reply

Your email address will not be published. Required fields are marked *